Hematology News

In patients with atrial fibrillation and cancer, non-vitamin K antagonist oral anticoagulants outperformed warfarin in thrombotic and bleeding endpoints, according to findings published in Stroke.

TV or not TV: The relationship between viewing it and venous thromboembolism risk, when accounting for physical activity and other risk factors, is the question.

Adults with obesity who undergo gastric bypass are five times more likely to develop anemia compared with those receiving nonsurgical obesity care, highlighting the importance of long-term adherence to nutritional supplementation.

Early administration of full-dose heparin slowed the thrombo-inflammatory process and reduced the risk for severe disease and death among moderately ill hospitalized patients with COVID-19, according to a study published in MedRxiv.

ASH will present honorific awards to several hematologists during this year’s ASH Annual Meeting, scheduled for Dec. 11-14.

A single IV dose of the factor XI monoclonal antibody abelacimab appeared superior to daily enoxaparin for preventing venous thromboembolism after total knee arthroplasty, according to randomized study results.

Iron replacement with IV ferumoxytol appears effective and safe for iron-deficient pregnant women with anemia in their second or third trimester, according to study results published in Therapeutic Advances in Hematology.

In a meta-analysis, researchers observed that severe direct oral anticoagulant-related bleeding death was relatively frequent, despite treatment with reversal agents, and that achieving hemostasis greatly improved survival.

The FDA approved dabigatran etexilate oral pellets for multiple indications.

The ACTIV-4B trial evaluating antithrombotic therapy in patients with symptomatic COVID-19 has been stopped early due to low event rates, Brigham and Women’s Hospital announced.